ArticleCancer innovation2024

A lactate-responsive gene signature predicts the prognosis and immunotherapeutic response of patients with triple-negative breast cancer.

Kaixiang Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.